Deletion of the ST2 proximal promoter disrupts fibroblast‐specific expression but does not reduce the amount of soluble ST2 in circulation

IL‐33 signals through ST2, which is expressed either as a full‐length signaling receptor or a truncated soluble receptor that can suppress IL‐33 activity. Previous data suggest that soluble ST2 mRNA in fibroblasts is coupled to a serum‐inducible proximal promoter, while full‐length ST2 expression in...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of immunology Vol. 42; no. 7; pp. 1863 - 1869
Main Authors Lipsky, Brian P., Toy, Dean Y., Swart, David A., Smithgall, Molly D., Smith, DirkE
Format Journal Article
LanguageEnglish
Published Germany Wiley Subscription Services, Inc 01.07.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:IL‐33 signals through ST2, which is expressed either as a full‐length signaling receptor or a truncated soluble receptor that can suppress IL‐33 activity. Previous data suggest that soluble ST2 mRNA in fibroblasts is coupled to a serum‐inducible proximal promoter, while full‐length ST2 expression in immune cells is directed from a distal promoter. In order to better understand the function of the alternative promoters and how they ultimately affect the regulation of IL‐33, we generated a mouse in which the ST2 proximal promoter is deleted. Promoter deletion had no impact on ST2 expression in mast cells or their ability to respond to IL‐33. In contrast, it resulted in a complete loss of both soluble and full‐length ST2 mRNA in fibroblasts, which corresponded with both an inability to secrete soluble ST2 and a defect in IL‐33 responsiveness. Importantly, in spite of the fibroblast defect, soluble ST2 concentrations were not reduced in the serum of naïve or allergen‐exposed knockout mice. In summary, we found that ST2 promoter usage is largely cell‐type dependent but does not dictate splicing. Moreover, the proximal promoter is not a major driver of circulating soluble ST2 under the conditions tested.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0014-2980
1521-4141
DOI:10.1002/eji.201142274